Novel prognostic tools that identify high-risk follicular lymphoma

被引：1
|
作者：
Luminari, Stefano [1 ,2 ]
机构：
[1] Azienda Unita Sanit Locale IRCCS, Hematol Unit, Reggio Emilia, Italy
[2] Univ Modena & Reggio Emilia, Surg Med & Dent Dept Morphol Sci Related Transpla, Reggio Emilia, Italy
来源：
HEMASPHERE | 2019年 / 3卷
关键词：
PROGRESSION-FREE SURVIVAL; MINIMAL RESIDUAL DISEASE; METABOLIC TUMOR VOLUME; POOLED ANALYSIS; VALIDATION; TRIAL;
D O I：
10.1097/HS9.0000000000000214
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Take home messages In 20% to 30% of patients with follicular lymphoma (FL), the disease shows an aggressive behavior. Novel biomarkers are available in FL each with a different ability to identify high-risk patients. Further improvement in the management of FL will likely be achieved by means of risk adapted therapies.
引用
收藏
页码：82 / 84
页数：3
相关论文
共 50 条
  • [31] Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life
    Clara Sortais
    Anne Lok
    Benoit Tessoulin
    Thomas Gastinne
    Béatrice Mahé
    Viviane Dubruille
    Nicolas Blin
    Cyrille Touzeau
    Anne Moreau
    Céline Bossard
    Pierre Peterlin
    Alice Garnier
    Thierry Guillaume
    Amandine Le Bourgeois
    Patrice Chevallier
    Philippe Moreau
    Christophe Leux
    Steven Le Gouill
    Annals of Hematology, 2020, 99 : 1595 - 1604
  • [32] Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life
    Sortais, Clara
    Lok, Anne
    Tessoulin, Benoit
    Gastinne, Thomas
    Mahe, Beatrice
    Dubruille, Viviane
    Blin, Nicolas
    Touzeau, Cyrille
    Moreau, Anne
    Bossard, Celine
    Peterlin, Pierre
    Garnier, Alice
    Guillaume, Thierry
    Le Bourgeois, Amandine
    Chevallier, Patrice
    Moreau, Philippe
    Leux, Christophe
    Le Gouill, Steven
    ANNALS OF HEMATOLOGY, 2020, 99 (07) : 1595 - 1604
  • [33] Prognostic Factors in Follicular Lymphoma
    Relander, Thomas
    Johnson, Nathalie A.
    Farinha, Pedro
    Connors, Joseph M.
    Sehn, Laurie H.
    Gascoyne, Randy D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (17) : 2902 - 2913
  • [34] Primary intestinal follicular lymphoma: How to identify follicular lymphoma by routine endoscopy
    Iwamuro, Masaya
    Kawai, Yoshinari
    Takata, Katsuyoshi
    Kawano, Seiji
    Yoshino, Tadashi
    Okada, Hiroyuki
    Yamamoto, Kazuhide
    WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY, 2013, 5 (01): : 34 - 38
  • [35] Follicular Lymphoma in China: Systematic Evaluation of Follicular Lymphoma Prognostic Models
    Li, Yanan
    Zhang, Yan
    Wang, Wei
    Wei, Chong
    Zhao, Danqing
    Zhang, Wei
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 1385 - 1393
  • [36] How to Identify the Asymptomatic High-Risk Patient?
    Schuijf, Joanne D.
    Achenbach, Stephan
    Zoghbi, William A.
    Boersma, Eric
    Raggi, Paolo
    Weber, Michael
    Nagel, Eike
    Narula, Jagat
    Wackers, Frans J. Th.
    Poldermans, Don
    Bax, Jeroen J.
    CURRENT PROBLEMS IN CARDIOLOGY, 2009, 34 (11) : 539 - 577
  • [37] How to identify a high-risk surgical patient?
    Schmidt, Andre P.
    Stefani, Luciana C.
    BRAZILIAN JOURNAL OF ANESTHESIOLOGY, 2022, 72 (03): : 313 - 315
  • [38] A Novel Pathological Prognostic Score (PPS) to Identify "Very High-Risk" Patients: a Multicenter Retrospective Analysis of 506 Patients with High Risk Gastrointestinal Stromal Tumor (GIST)
    Liu, Xuechao
    Qiu, Haibo
    Wu, Zhiming
    Zhang, Peng
    Feng, Xingyu
    Chen, Tao
    Li, Yong
    Tao, Kaixiong
    Li, Guoxin
    Sun, Xiaowei
    Zhou, Zhiwei
    JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 22 (12) : 2150 - 2157
  • [39] A Novel Pathological Prognostic Score (PPS) to Identify “Very High-Risk” Patients: a Multicenter Retrospective Analysis of 506 Patients with High Risk Gastrointestinal Stromal Tumor (GIST)
    Xuechao Liu
    Haibo Qiu
    Zhiming Wu
    Peng Zhang
    Xingyu Feng
    Tao Chen
    Yong Li
    Kaixiong Tao
    Guoxin Li
    Xiaowei Sun
    Zhiwei Zhou
    Journal of Gastrointestinal Surgery, 2018, 22 : 2150 - 2157
  • [40] FRONT-LINE RISK-ADAPTED IMMUNOCHEMOTHERAPY IMPROVES OUTCOME IN INTERMEDIATE/HIGH-RISK PATIENTS WITH FOLLICULAR LYMPHOMA
    Prochazka, V.
    Papajik, T.
    Kubova, Z.
    Rozmanova, S.
    Jarosova, M.
    Indrak, K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 400 - 400
12345